Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
Article
2020 CPT Code Changes: What You Need to Know
CPT Copyright 2020 American Medical Association.
Auto Casualty
Virtual Event
COVID-19: Effects on Auto Insurance Industry [Podcast]
On-Demand
Social distancing guidelines across the country have led to fewer cars on the road and, as a result, a decline in auto accidents.
Workers' Comp
Virtual Event
The Future of Technology in the Workers’ Comp Industry
On-Demand
Technology and COVID-19 are changing the workers’ compensation industry.
Auto Casualty
Virtual Event
Webcast: Michigan No-Fault Reform-An Expert's Guide to the New Utilization Review Administrative Rules
On-Demand
As a part of Michigan’s no-fault auto insurance reform, new utilization review administrative rules will go into effect for insurance carriers on J
Workers' Comp
Virtual Event
Work Comp: COVID-19 Effects and Lasting Impacts [Podcast]
On-Demand
In this podcast series, Mitchell | Genex subject matter experts from across the business share their expertise on how the COVID-19 pandemic is affe
Workers' Comp
Virtual Event
Webcast: Workers’ Compensation Legislation Addressing Essential Workers Affected by COVID-19
On-Demand
As the United States continues to battle COVID-19, many states have taken emergency legislative and regulatory actions to address potential issues